For the past 18 months, ResMed Chief Executive Mick Farrell has been publicly outspoken in urging that medical devices get priority access to semiconductors amid global chip shortages coming out of the pandemic. Now, with macro-economic headwinds slowing demand for certain consumer electronics, the bottleneck of chips available for medical devices, such as ResMed’s connected sleep apnea machines and ventilators, has begun to ease. And the results showed up in the San Diego company’s top-line financial performance last quarter. ResMed rung up sales of $1.03 billion for its fiscal second quarter…
